SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,333 | -34.2% | 25,774 | 0.0% | 0.00% | – |
| Q2 2023 | $29,382 | -24.0% | 25,774 | 0.0% | 0.00% | – |
| Q1 2023 | $38,661 | -49.7% | 25,774 | -50.0% | 0.00% | – |
| Q4 2022 | $76,806 | +92.0% | 51,548 | +100.0% | 0.00% | – |
| Q3 2022 | $40,000 | -32.2% | 25,774 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -88.7% | 25,774 | -88.6% | 0.00% | – |
| Q1 2022 | $521,000 | -57.3% | 225,572 | +7.3% | 0.00% | – |
| Q4 2021 | $1,220,000 | -31.0% | 210,292 | +25.2% | 0.00% | – |
| Q3 2021 | $1,768,000 | +81.1% | 168,031 | +68.0% | 0.00% | – |
| Q2 2021 | $976,000 | +14.3% | 100,000 | +70.2% | 0.00% | – |
| Q1 2021 | $854,000 | – | 58,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,540,920 | $2,311,380 | 0.45% |
| Deuterium Capital Management, LLC | 11,000 | $16,500 | 0.03% |
| Duquesne Family Office | 100,000 | $150 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $169,350 | 0.00% |
| LEO BROKERAGE, LLC | 14,845 | $22,268 | 0.00% |
| Ergoteles LLC | 15,521 | $23,282 | 0.00% |
| UBS Group AG | 3,440 | $5,160 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 15,276 | $22,914 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $17,355 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 89,986 | $134,979 | 0.00% |